Bone Fracture Treatment Using Bone Marrow Aspirate and Bone Marrow Aspirate Concentrate: A Narrative Review
Journal of Clinical Medicine · 17.11.2026 · 15 (22) · 9004
DOI: 10.3390/jcm15229004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 17.11.2026. Verfasst von Jae Sun Lee und 5 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea.
Abstract (Originalsprache)
Background/Objectives: Bone fractures, particularly in older adults with osteoporosis, remain a major clinical challenge due to delayed union and nonunion despite advances in surgical techniques. This narrative review aimed to summarize the clinical evidence on unconcentrated bone marrow aspirate (BM) and bone marrow aspirate concentrate (BMAC) for promoting fracture healing and union.
Methods
In this narrative review, clinical studies of BM or BMAC used as an adjunct to surgical treatment or as a percutaneous treatment for nonunion and delayed union were identified through a literature search and summarized descriptively. Outcomes included radiological union, clinical union, time to union, and reported complications.
Results
In surgical settings (distraction osteogenesis, congenital pseudarthrosis, atypical femoral fractures, and atrophic mandibular fractures), one randomized trial and three non-randomized comparative studies, in all of which BMAC was part of a combined intervention, reported faster healing or a shorter time to union (three studies) and fewer complications or refractures (two studies). In 13 studies of percutaneous injection for nonunion, 11 of which used unconcentrated BM, reported union rates ranging from 50% to 94.4%, and the unweighted median of the study-level summary time to radiological union was 20.7 weeks. In two BMAC studies, union or callus formation was associated with the number or concentration of progenitor cells delivered. One uncontrolled series of infected tibial nonunion without bone defects reported union and resolution of infection after BMAC containing granulocyte precursors, without antibiotics.
Conclusions
BM- and BMAC-based interventions have been associated with favorable outcomes in selected clinical settings. However, small samples, uncontrolled designs, heterogeneous products and populations, and concomitant treatments limit certainty about the independent contribution of BMAC and its safety relative to standard treatment. The available evidence is of low certainty. Further large-scale randomized controlled trials are warranted to establish standardized protocols, optimize preparation methods, and evaluate long-term outcomes.
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
Zitieren
APA
Lee, J. S., Lee, H. H., Kang, K., Oh, S. H., Jo, H., & Chae, D. (2026). Bone Fracture Treatment Using Bone Marrow Aspirate and Bone Marrow Aspirate Concentrate: A Narrative Review. Journal of Clinical Medicine, 15(22), 9004. https://doi.org/10.3390/jcm15229004
Vancouver
Lee JS, Lee HH, Kang K, Oh SH, Jo H, Chae D. Bone Fracture Treatment Using Bone Marrow Aspirate and Bone Marrow Aspirate Concentrate: A Narrative Review. Journal of Clinical Medicine. 2026;15(22):9004. doi:10.3390/jcm15229004
BibTeX
@article{Lee2026,
author = {Lee, Jae Sun and Lee, Hyun Hee and Kang, Kyung-Yil and Oh, Seong Ho and Jo, Hannah and Chae, Dong-Sik},
title = {Bone Fracture Treatment Using Bone Marrow Aspirate and Bone Marrow Aspirate Concentrate: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {22},
pages = {9004},
doi = {10.3390/jcm15229004}
}
EUVIMED